Eric Lang

Title: The Innovations of Eric Lang

Introduction

Eric Lang is an accomplished inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of pain management through his innovative approaches and patented methods. With a focus on minimizing systemic effects, his work has the potential to improve patient care and treatment outcomes.

Latest Patents

Eric Lang holds a patent for the invention titled "Intrathecal or epidural administration of 3-[(1S,25)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol." This invention relates to a method of providing pain management in a subject, ensuring that the administration of the composition does not result in any non-central nervous system mediated systemic effect. The method specifically involves administering 3-[(1S,2S)-3-(dimethylamino)-1-ethyl-2-methyl-propyl]-phenol in a space that is void of thrombocytes. This innovative approach highlights his commitment to enhancing pain management techniques.

Career Highlights

Throughout his career, Eric Lang has worked with notable companies, including Gruenenthal GmbH and Grünenthal GmbH. His experience in these organizations has allowed him to develop and refine his expertise in the field of pharmaceuticals and pain management.

Collaborations

Eric has collaborated with several professionals in his field, including Petra Bloms-Funke and Derek John Saunders. These collaborations have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Eric Lang's innovative contributions to pain management through his patented methods demonstrate his dedication to improving patient care. His work continues to influence the field and offers promising solutions for effective pain management.